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Introduction
As the Obama administration moves to
enact meaningful and comprehensive health
care reform in the United States, tobacco
control must be elevated as a public health
priority [1]. Though tobacco control efforts
have been recognized as a top public health
achievement of the 20th century [2], tobacco
use continues to be the leading preventable
cause of death in the US [3]. As Box 1 shows,
the US bears a heavy burden from the health
and fiscal effects ofsmoking.Thus,continued
progress in preventing tobacco use and
promoting smoking cessation must be a
leading priority for health care reform under
the new administration. This policy paper
gives the current status of tobacco control
policies, initiatives, and legislative action at
the time of going to press.
A bill to grant the US Food and Drug
Administration (FDA) regulatory authority
over tobacco products [4] was the central
element of federal tobacco control efforts
during the Bush administration. The bill,
recently passed by the US House of
Representatives, was drafted to obtain
approval from a Republican Congress
and the Bush White House. With a new
administration in place and broad political
and public support for health care reform,
however, a comprehensive reassessment of
the federal agenda on tobacco control is
needed. Efforts to pass strong legislation to
grant FDA regulatory authority over
tobacco products must continue, but can
no longer be the central focus of tobacco
control efforts at the federal level.
This paper explores the potential of the
US government (USG), with its extraordi-
nary reach and extensive infrastructure, to
develop and implement a policy-coherent
agenda—defined as a series of consistent
and mutually supportive institutional ap-
proaches to an important public health
problem—to reduce tobacco-related mor-
bidity and mortality. Tobacco use preven-
tion and cessation measures have public
support from both nonsmokersand smokers;
in fact, 70% of smokers desperately want to
quit [5]. These measuresalsomitigate health
care costs [6]. To fully realize these cost
savings and to answer the public’s support
for tobacco control measures, however, a
functional approach requires policy integra-
tion across agencies, especially those under
the Chief Executive, and support from the
legislative branch of government.
Prioritizing Health
Over the past half-century, health has
occupied a prominent role on the policy
agenda for many US presidents, with some
administrations having made attempts to
achieve policy coherence on specific
health issues. For example, President
Johnson identified reducing heart disease,
cancer, and stroke as a national health
priority [7], and President Nixon initiated
a ‘‘War on Cancer’’ [8]. President Clinton
coordinated federal action on HIV/AIDS,
an action built on by President George W.
Bush’s President’s Emergency Plan for
AIDS Relief (PEPFAR) program [9].
In spite of successive surgeon general’s
reports and the recent recommendations
from the Institute of Medicine (IOM) [10]
and the President’s Cancer Panel [11],
comprehensive and concerted national
action to reduce the burden of tobacco
use has not been evident. What has been
lacking is forceful and committed leader-
ship from both the Office of the President
and the US Congress. Yet none of the
recent reports that offer national plans to
end the tobacco epidemic fully appreciate
the numerous federal agencies that have a
role to play in a policy-coherent federal
tobacco control agenda. The surgeon
general’s 2000 report emphasized the role
of state governments [12], and the IOM’s
report (‘‘Ending the Tobacco Problem: A
Blueprint for the Nation’’) urged strong
Congressional action [10], while the
President’s Cancer Panel extensively cov-
ered broad federal actions [11]. We focus
on the breadth of USG departments and
agencies to examine how strong leadership
from the Office of the President can
marshal the considerable resources of
many agencies in order to reduce the
burden of tobacco use in the US.
Federal Policies and Programs
in Tobacco Control
USG agencies cover a range of popula-
tions, environments, products, and func-
tions that may effectively support tobacco
control. However, they are uncoordinated
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message to be considered a coherent
national strategy. To understand possible
future federal action, we first describe
briefly the roles of the current most
important USG agencies in tobacco con-
trol. A more detailed discussion of existing
policies and programs can be found in
Text S1.
Department of Health and Human
Services (DHHS)
DHHS is the lead department for
current tobacco control activities. The
potential of the department to significantly
reduce the level of smoking and the
burden from tobacco-related diseases
through its vast infrastructure is enormous,
but DHHS has faced a number of barriers
in this role. Policy coherence in tobacco
control across the federal government
begins with mobilization of the resources
and infrastructure within DHHS.
The Centers for Disease Control and
Prevention (CDC), one of 12 agencies
within DHHS, houses the National To-
bacco Control Program under the Office
on Smoking and Health (OSH). It pro-
vides technical assistance to states and
engages in programmatic activities while
the National Institutes of Health (NIH),
mainly through the National Cancer
Institute, National Institute on Drug
Abuse, and the Fogarty International
Center, is the lead agency for tobacco
control research. Both CDC and NIH also
play critical tobacco use surveillance roles
[13]. The NIH Tobacco and Nicotine
Research Interest Group (TANRIG) was
formed in January 2003 with the goal of
increasing collaboration, coordination,
and communication of tobacco- and
nicotine-related research among NIH
institutes and centers, and with partnering
DHHS agencies.
Smoking cessation services are provided
to specific populations through various
DHHS programs, such as Medicare and
Medicaid, the public health insurance
programs for the elderly and the poor,
respectively [14]. The coverage of these
programs, however, is insufficient and
needs to be strengthened [15]. Other
DHHS agencies have a variety of concerns
and jurisdictions relative to tobacco con-
trol. For example, the Agency for Health-
care Research and Quality [16], CDC
[17], and the US Public Health Service
[18] produce important best practices
guidelines for smoking cessation. The
Substance Abuse and Mental Health
Services Administration (SAMHSA) has a
mandate to enforce a state minimum
tobacco product purchase age [19].
Non-Health Agency Tobacco-
Related Concerns
The Federal Trade Commission, a
consumer protection and fair competition
agency within the USG, oversees cigarette
package warning labels [20] and has broad
authority over tobacco product marketing
and advertising, collects data on the
marketing expenditures, and conducts
tests to assess the tar and nicotine levels
of cigarettes.
With the creation of the Department of
Homeland Security, responsibility for the
collection and enforcement of tobacco
excise taxes has been split between the
Department of The Treasury and the
Department of Justice (DOJ). The Trea-
sury department, through the Alcohol and
Tobacco Tax and Trade Bureau, is
responsible for the collection of tobacco
excise taxes. The Bureau of Alcohol,
Tobacco, Firearms and Explosives within
the DOJ is responsible for monitoring and
eliminating smuggling of tobacco within
and to the US.
Department of Veterans Affairs (VA),
responsible for providing services to for-
mer soldiers, supports smoking cessation
through its health facilities.
Tobacco Control Priorities at
the Federal Level
Three future tobacco control issues
should be prioritized within the federal
government: ratification of the World
Health Organization (WHO) Framework
Convention on Tobacco Control (FCTC),
authorizing the FDA to regulate tobacco
products, and settling the DOJ’s Racketeer
Influenced and Corrupt Organizations Act
(RICO) case against the tobacco industry.
Each of these issues should be part of a
larger policy-coherent plan for the federal
government on tobacco control, but are
highlighted here for their significance and
potential impact.
The FCTC is the first-ever global public
health treaty [21]. It was developed to
counter the globalization of tobacco use
and the growing burden of disease from
tobacco use worldwide. Though it was
signed by then-DHHS Secretary Tommy
Thompson, President Bush did not send it
to the Senate for ratification. Ratification
of the FCTC should be a leading priority
within health reform for the Obama
administration. It will provide the needed
impetus to revive comprehensive tobacco
control efforts at the national level and act
as a framework for developing a national
tobacco control agenda.
There is little dispute over whether the
FDA should regulate tobacco products;
there is controversy, however, over wheth-
er the existing bill is the appropriate
legislation to grant that authority [22,23].
Granting FDA authority over tobacco
products should be a high priority within
health reform. The Obama administration
should work to ensure that legislation
contains the strongest possible language
and conditions beneficial to public health
without concessions to the tobacco indus-
try.
Box 1. Health and Economic Burdens of Smoking, United States
Tobacco use…
…is the leading preventable cause of death. At least 443,000 annual
premature deaths in the United States from 2000–2004 were attributable to
smoking [33].
…leads to premature death. During 2000–2004, 5.1 million years of
productive life were lost due to cigarette smoking and exposure to passive
smoking per year [33].
…contributes to health disparities. African Americans, Native Americans/
Alaska Natives, the poor, and people with lower educational attainment suffer
from a higher burden of disease and disability from smoking.
…is a major cause of cancer in the lung, larynx, pharynx, mouth, and
bladder. It also causes cancer in the pancreas, cervix, kidney, and stomach.
…causes deaths from heart disease, stroke, and chronic obstructive
pulmonary disease.
…is a fiscal burden. Cigarette smoking and exposure to tobacco smoke results
in productivity losses of $96.8 billion annually [33] and over $75 billion in annual
US medical expenditures [6].
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tobacco industry defrauded the American
public and violated two sections of the
RICO Act in the DOJ’s case against the
tobacco industry, United States v. Philip
Morris [24]. Though the case is currently
in appeal, Judge Kessler’s remedies for
corrective actionorderthetobacco industry
to cease false and deceptive activities. They
also call for government regulatory author-
ity over tobacco products and assertion of
greater oversight of the industry through
disclosure of industry documents and
reporting of disaggregated market data.
Bolstering the smoking cessation capac-
ity of the health care system will also be a
tobacco control priority at the federal level
if the Obama administration successfully
advances its health care reform agenda. A
commitment to prevention, long neglected
within the US health system, is an essential
component of health care reform in the
US [1,25]. Successful reform of the US
health care system into a universally
accessible, prevention-oriented system
would include a strengthened infrastruc-
ture to support smoking cessation [26].
Expanding USG Tobacco
Control Efforts
The current financial and political
environment makes it difficult for the
USG to contemplate any new programs
aside from those that revive the economy
and seek a resolution to the conflicts in
Iraq and Afghanistan. Tobacco control,
however, is nonetheless a critical element
of the domestic health care reform agenda
for two reasons. First, it can be initiated at
little to no cost to the government.
Creating smoke-free environments and
engaging in public education are simple
first steps that require little more than
asserting tobacco control as a public
health priority. Programs and policies that
require government expenditure, includ-
ing increased provision of smoking cessa-
tion services, can be introduced as the
country’s economic condition stabilizes.
Second, the economic return on invest-
ment in tobacco control could be remark-
able [27,28]. Thus, renewed commitment
and mobilization within the programs and
agencies described above, as well as others
in the federal government, may be critical
components of any health reform strategy
for the new administration. The following
agencies have a potentially important role
to play in a revitalized national approach.
Smoke-Free Environments
The Occupational Safety and Health
Administration, Environmental Protection
Agency, Department of Housing and
Urban Development, Department of the
Interior, and Department of Defense all
have jurisdiction over spaces that can be
made smoke-free.
Smoking Cessation
All agencies that provide health services,
and those employing federal employees,
especially the VA, should provide easy
access to comprehensive smoking cessation
services [15].
Public Education
CDC, NIH, and non-federal partners
can collaboratively sponsor a national
mass media counter-marketing campaign.
The US Department of Education and US
Department of Agriculture (USDA) also
have public education roles.
Research and Surveillance
For agencies like CDC and NIH to
pursue tobacco control research and
surveillance, oversight authority given to
the Office of Management and Budget,
the White House office responsible for
overseeing the execution of the federal
budget in executive branch agencies, to
approve federal surveys and manage
scientific information must be relaxed or
removed [29].
Product Regulation
Granting FDA regulatory authority
over tobacco products is an essential part
of a national tobacco program. Expanded
regulation of tobacco as a crop and crop
diversion programs by USDA are also
needed [30].
Industry Regulation
The DOJ must insist on strong remedies
to the industry’s behavior in the RICO
case. In general, the USG should not
obstruct litigation against tobacco compa-
nies and should allow judicial processes to
play out in both individual and class action
cases. Current regulation and surveillance
of tobacco product sales, marketing, and
promotion by the Federal Trade Commis-
sion and SAMHSA should be strength-
ened through FDA regulation of tobacco
products or other legislative powers. US
warning labels, for example, have been
shown to have less impact than those in
other countries [31].
Foreign Policy on Tobacco and
Health Trade Policy
The Doggett Amendment, which pro-
hibits the Justice, State, and Commerce
Departments from promoting the interests
of the tobacco industry overseas (except in
cases of discriminatory policies) [32],
should be made into law. In trade
agreements, the US Trade Representative
should treat tobacco products as excep-
tional goods and, at minimum, be re-
quired to show that trade in tobacco
products will not cause public health harm
before being included in trade agreements
and settlements.
FCTC
The United States can demonstrate
strong international leadership on tobacco
control by ratifying the treaty and moving
quickly to begin its implementation. Con-
cerns over the treaty’s implementation,
including state compliance with FCTC
binding obligations, are unwarranted un-
der the FCTC’s accommodations for
differences in national governmental struc-
ture and laws.
The US can also provide foreign aid
and technical assistance to support other
countries in implementation of the FCTC.
These efforts may involve NIH to support
international research, CDC to support
program implementation, USDA to sup-
port crop diversification, and USAID
health programs to support development
of health systems approaches to tobacco
control.
Summary and Conclusions
The wide public support and increasing
political momentum for health care re-
form is an opportunity to advance the
progress of tobacco control efforts, reduc-
ing the health toll on Americans and the
economic burden on the American health
care system. National plans to substantially
reduce the burden of tobacco use have
been put forth [10,11]. Yet those plans are
unlikely to be fully realized without the
strong and committed leadership of the
Office of the President and support of
Congress. Existing policies and programs
and opportunities for expansion of tobacco
control within the federal government lead
to the following recommendations for
action.
Presidential Leadership
President Obama should make a strong
public commitment and mobilize the vast
capacity of the USG to achieve policy
coherence in tobacco control. This is
especially true for mobilization of USG
agencies to reorganize to facilitate inter-
agency cooperation. An Executive lead
organization should be designated to
develop a national tobacco control plan.
Coordination and leadership for a national
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in a highly visible and reputable lead
agency, suchas DHHSor the White House
Office of Health Reform, with additional
programmatic resources drawn from other
agencies. Lead agency staff would coordi-
nate programmatic activities with support
from the White House. The Obama
administrationmustalsoprovideleadership
through the budget process with Congress.
Financial commitment from the US Con-
gress and political support from the White
House would facilitate participation from
across agencies.
Participation and Buy-In
A comprehensive national tobacco con-
trol plan would require broad-based
participation and buy-in. The lead agency
should work with partners including non-
governmental organizations, foundations,
and professional organizations and socie-
ties to develop public support for the
program. A broadly inclusive and neutral-
ly facilitated process of stakeholder con-
sensus building could be used to develop
the central policies of a national tobacco
control plan.
Interaction with the States
Though the current network of state
and local tobacco programs has benefited
greatly from the leadership of the CDC–
OSH National Tobacco Control Program,
state and local governments are wary of
federal legislative action on tobacco con-
trol. Concerns over preemption of state
and local legislation by weak federal laws
are bolstered by the use of preemption as
an explicit strategy of the tobacco industry
to subvert local tobacco control efforts.
The actions of the federal government,
adjusted to address concerns over preemp-
tion, should act to complement and bolster
those of the states.
Though a vast majority of the success in
tobacco control has been at the state and
municipal level, federal involvement in
tobacco control is needed for four reasons.
First, some actions, such as product
regulation and control of smuggling, are
beyond the abilities of states. Second, the
infrastructure of the federal government is
so vast as to enable a coordinated and
directed tobacco control program across
states. Third, federal involvement can help
to strengthen the tobacco control efforts of
states with less effective programs. Last,
areas such as foreign policy and the
military fall solely within the purview of
the federal government.
Implications for Global Tobacco
Control
As the implementation of the FCTC
proceeds, countries will be implementing
an array of tobacco control policies as part
of their international commitment. The
principle of policy coherence outlined in
this paper for the US may spur countries
to think more broadly across government
functions about the ways in which the
FCTC is implemented. Action toward
policy coherence in the United States,
with its substantial material and human
capital resources, may act as a model for
other countries to follow, including both its
successes and its failures.
A comprehensive federal agenda on
tobacco control will be a critical part of
the Obama administration’s health care
reform efforts. After eight years of neglect
on the leading cause of death in the
United States and a prolonged legislative
conundrum over tobacco products and
nicotine regulation, a drastic policy
change—one geared toward policy coher-
ence—is in order. Most urgently, ratifica-
tion of the FCTC, FDA regulatory
authority over tobacco products, and a
firm resolution to the RICO case must
become reality. For these areas to be
adequately addressed and carried out,
however, USG agencies must be brought
together and empowered to take concerted
action on tobacco control that results in
true policy coherence. We believe this
change in direction is based on sound
science, is acceptable to the almost 80% of
nonsmoking Americans and the 70% of
smoking Americans who want to quit, and
in the best fiscal and health interests of the
United States. It is change that we not
only need, but is long overdue.
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